Identification and properties of an atypical catalytic subunit (p34PSK-J3/cdk4) for mammalian D type G1 cyclins
The DOI matches its Crossref record; 61 of the 66 references it cites were found in a registry or an index.
Abstract
Murine D type cyclins associate with a catalytic subunit (p34PSK-J3) with properties distinct from known cyclin-dependent kinases (cdks). Mouse p34PSK-J3 shows less than 50% amino acid identity to p34cdc2, p33cdk2, and p36cdk3, lacks a PSTAIRE motif, and does not bind to p13suc1. Cyclin D1-p34PSK-J3 complexes accumulate in macrophages during G1 and decline in S phase, whereas complexes involving cyclins D2 and D3 form in proliferating T cells. Although histone H1 kinase activity is not detected in cyclin D or PSK-J3 immunoprecipitates, cyclin D-p34PSK-J3 complexes assembled in vitro stably bind and phosphorylate the retinoblastoma gene product (pRb) and an Rb-like protein (p107) but do not interact with pRb mutants that are functionally inactive. Thus, p34PSK-J3 is a cyclin D-regulated catalytic subunit that acts as an Rb (but not H1) kinase.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Unlike CDKs 1 and 2 that phosphorylate many hundreds of cellular protein substrates (13), CDK4 is a surprisingly fastidious enzyme that has a restricted propensity to phosphorylate the retinoblastoma protein (RB1, hereafter RB) and two other RB-family proteins [RB2 (p130), RBL1 (p107)] (11, 14-16), but very few other substrates (17).”
From Targeting CDK4 and CDK6: From Discovery to Therapy (2016) · cites this paper as [11]
In the citing paper
“The presumption that D-type cyclins might allosterically regulate a novel CDK was validated by the discovery of CDK4, which was revealed to physically bind to, and be enzymatically activated by, any of the three D-type cyclins (11).”
From Targeting CDK4 and CDK6: From Discovery to Therapy (2016) · cites this paper as [11]
Citations
Cites
DNA sequencing with chain-terminating inhibitors
Sanger, F., Nicklen, S., & Coulson, A. R. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.12.5463 · Cited by 68,572 · cited 1×
“DNA sequences were determined by dideoxynucleotide chain termination (Sanger et al., 1977) using double-stranded plasmid DNA tem-”
MethodThe Protein Kinase Family: Conserved Features and Deduced Phylogeny of the Catalytic Domains
Hanks, S. K., Quinn, A. M., & Hunter, T. (1988) · Science · doi:10.1126/science.3291115 · Cited by 5,039
Self-citationCheckpoints: Controls That Ensure the Order of Cell Cycle Events
Hartwell, L. H., & Weinert, T. A. (1989) · Science · doi:10.1126/science.2683079 · Cited by 3,021
Universal control mechanism regulating onset of M-phase
Nurse, P. (1990) · Nature · doi:10.1038/344503a0 · Cited by 2,831 · cited 2×
“Although the complex of p34*z and cyclin B appears to act as a regulator of mitotic entry and exit in all eukaryotic cells (Nurse, 1990), mammalian Gl cyclins have no exact cognates in yeast, and their appearance in higher eukaryotes may reflect levels of specialization inherent in more complex multicellular organisms.”
BackgroundG 1 Events and Regulation of Cell Proliferation
Pardee, A. B. (1989) · Science · doi:10.1126/science.2683075 · Cited by 2,182
A Manual of Methods for Baculovirus Vectors and Insect Cell Culture Procedures.
Summers, & Smith, G. (1987) · OakTrust (Texas A&M University Libraries) · Cited by 1,670
Cyclin A is required at two points in the human cell cycle.
Pagano, M., Pepperkok, R., Verde, F., Ansorge, W., & Draetta, G. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05135.x · Cited by 1,403
A novel cyclin encoded by a bcl1-linked candidate oncogene
Motokura, T., Bloom, T., Kim, H. G., Jüppner., H., Ruderman, J. V., Kronenberg, H. M., & Arnold, A. (1991) · Nature · doi:10.1038/350512a0 · Cited by 1,265
Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle
Matsushime, H., Roussel, M. F., Ashmun, R. A., & Sherr, C. J. (1991) · Cell · doi:10.1016/0092-8674(91)90101-4 · Cited by 1,167
Self-citationThe retinoblastoma protein is phosphorylated during specific phases of the cell cycle
Buchkovich, K., Duffy, L. A., & Harlow, E. (1989) · Cell · doi:10.1016/0092-8674(89)90508-4 · Cited by 995 · cited 1×
“Together, these data suggest that there may indeed be a physiological interplay between various cyclin D-p34PSKJ3 complexes and pRb, a tumor suppressor protein whose phosphorylation appears necessary for the GllS transition (Buchkovich et al., 1989; DeCaprio et al., 1989; Ludlow et al., 1990).”
Background
Cited by
CDK inhibitors: positive and negative regulators of G1-phase progression
Sherr, C. J., & Roberts, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.12.1501 · Cited by 6,115
“Cyclin D-dependent kinases are fastidious in their substrate specificity, phosphorylating Rb but not the canonical CDK substrate histone H1 (Matsushime et al. 1992; Ewen et al. 1993; Kato et al. 1993).”
BackgroundSelf-citationThe p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.
Wade Harper, J. (1993) · Cell · doi:10.1016/0092-8674(93)90499-g · Cited by 5,651
Cell cycle, CDKs and cancer: a changing paradigm
Malumbres, M., & Barbacid, M. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2602 · Cited by 3,957
A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
Serrano, M., Hannon, G. J., & Beach, D. (1993) · Nature · doi:10.1038/366704a0 · Cited by 3,650
p21 is a universal inhibitor of cyclin kinases
Xiong, Y., Hannon, G. J., Zhang, H., Casso, D., Kobayashi, R., & Beach, D. (1993) · Nature · doi:10.1038/366701a0 · Cited by 3,368
Metadata
- Authors
- Matsushime, H., Ewen, M. E., Strom, D. K., Kato, J.-Y., Hanks, S. K., Roussel, M. F., & Sherr, C. J.
- Affiliations
- St. Jude Children's Research Hospital (US)
- Harvard University (US)
- Vanderbilt University (US)
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 1992-10
- Volume
- 71
- Issue
- 2
- Pages
- 323-334
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W1990925999
- Cited by
- 897
- References
- 66
- Citations by year
- 2026: 1 · 2025: 12 · 2024: 7 · 2023: 13 · 2022: 16 · 2021: 11 · 2020: 18 · 2019: 10 · 2018: 16 · 2017: 18 · 2016: 10 · 2015: 11 · 2014: 8 · 2013: 20 · 2012: 14
- FWCI
- 34.41
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Cell (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (7r29gm038793-04, 5r35ca047064-05)
- National Cancer Institute (R35-CA47064, P01-CA21765)
- National Institute of General Medical Sciences (R29-GM38793)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
- Keywords
- CDK4, cyclin D, G1 cyclins, retinoblastoma protein phosphorylation, p107, p13suc1, macrophages, T cell proliferation, histone H1 kinase, cell cycle regulation
- MeSH terms
- Amino Acid Sequence, Animals, Base Sequence, Cells, Cultured, Humans, Insecta, Macrophages, Molecular Sequence Data, Protein Kinases, Proto-Oncogene Proteins, Oncogene Proteins, G1 Phase, CDC2 Protein Kinase, Cyclins, Sequence Homology, Amino Acid, Cyclin-Dependent Kinases, Cyclin D1, Cyclin-Dependent Kinase 4, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Identification and properties of an atypical catalytic subunit (p34PSK-J3/cdk4) for mammalian D type G1 cyclins. https://app.cochat.ai/papers/10.1016/0092-8674(92)90360-o
- The paper
- Matsushime, H., Ewen, M. E., Strom, D. K., Kato, J.-Y., Hanks, S. K., Roussel, M. F., & Sherr, C. J. (1992). Identification and properties of an atypical catalytic subunit (p34PSK-J3/cdk4) for mammalian D type G1 cyclins. Cell. https://doi.org/10.1016/0092-8674(92)90360-o
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.